The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Machine Learning Prediction of Biomarkers from SNPs and of Disease Risk from Biomarkers in the UK Biobank
Published version of a preprint
Abstract
We use UK Biobank data to train predictors for 65 blood and urine markers such as HDL, LDL, lipoprotein A, glycated haemoglobin, etc. from SNP genotype. For example, our Polygenic Score (PGS) predictor correlates ∼0.76 with lipoprotein A level, which is highly heritable and an independent risk factor for heart disease. This may be the most accurate genomic prediction of a quantitative trait that has yet been produced (specifically, for European ancestry groups). We also train predictors of common disease risk using blood and urine biomarkers alone (no DNA information); we call these predictors biomarker risk scores, BMRS. Individuals who are at high risk (e.g., odds ratio of >5× population average) can be identified for conditions such as coronary artery disease (AUC∼0.75), diabetes (AUC∼0.95), hypertension, liver and kidney problems, and cancer using biomarkers alone. Our atherosclerotic cardiovascular disease (ASCVD) predictor uses ∼10 biomarkers and performs in UKB evaluation as well as or better than the American College of Cardiology ASCVD Risk Estimator, which uses quite different inputs (age, diagnostic history, BMI, smoking status, statin usage, etc.). We compare polygenic risk scores (risk conditional on genotype: PRS) for common diseases to the risk predictors which result from the concatenation of learned functions BMRS and PGS, i.e., applying the BMRS predictors to the PGS output.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimating glomerular filtration rate from serum creatinine and cystatin C
Inker, L. A., Schmid, C. H., Tighiouart, H., Eckfeldt, J. H., Feldman, H. I., Greene, T., Kusek, J. W., Manzi, J., Van Lente, F., Zhang, Y. L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114248 · Cited by 4,102
Buniello, A., MacArthur, J. A. L., Cerezo, M., Harris, L. W., Hayhurst, J., Malangone, C., McMahon, A., Morales, J., Mountjoy, E., Sollis, E., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1120 · Cited by 4,000
Khera, A. V., Chaffin, M., Aragam, K. G., Haas, M. E., Roselli, C., Choi, S. H., Natarajan, P., Lander, E. S., Lubitz, S. A., Ellinor, P. T., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0183-z · Cited by 2,953
Clinical use of current polygenic risk scores may exacerbate health disparities
Martin, A. R., Kanai, M., Kamatani, Y., Okada, Y., Neale, B. M., & Daly, M. J. (2019) · Nature Genetics · doi:10.1038/s41588-019-0379-x · Cited by 2,821
23andMe Research Team, Lee, J. J., COGENT (Cognitive Genomics Consortium), Social Science Genetic Association Consortium, Wedow, R., Okbay, A., Kong, E., Maghzian, O., Zacher, M., Nguyen-Viet, T. A., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0147-3 · Cited by 2,470
A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease
the CARDIoGRAMplusC4D Consortium (2015) · Nature Genetics · doi:10.1038/ng.3396 · Cited by 2,447
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.010 · Cited by 1,896
Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
Clarke, R., Peden, J. F., Hopewell, J. C., Kyriakou, T., Goel, A., Heath, S. C., Parish, S., Barlera, S., Franzosi, M. G., Rust, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902604 · Cited by 1,671
Assmann, G., Cullen, P., & Schulte, H. (2002) · Circulation · doi:10.1161/hc0302.102575 · Cited by 1,541
Genes mirror geography within Europe
Novembre, J., Johnson, T., Bryc, K., Kutalik, Z., Boyko, A. R., Auton, A., Indap, A., King, K. S., Bergmann, S., Nelson, M. R., et al. (2008) · Nature · doi:10.1038/nature07331 · Cited by 1,479
Research works printed but not linked: 97
- Veenstra, 2010, A formal risk-benefit framework for genomic tests: Facilitating the appropriate translation of genomics into clinical practice, Genet. Med., 12, 686, 10.1097/GIM.0b013e3181eff533 · DOI
- Amir, 2010, Assessing women at high risk of breast cancer: A review of risk assessment models, JNCI J. Natl. Cancer Inst., 102, 680, 10.1093/jnci/djq088 · DOI · Paper page
- Euesden, 2014, PRSice: Polygenic risk score software, Bioinformatics, 31, 1466, 10.1093/bioinformatics/btu848 · DOI · Paper page
- Abraham, 2014, Accurate and Robust Genomic Prediction of Celiac Disease Using Statistical Learning, PLOS Genet., 10, 1, 10.1371/journal.pgen.1004137 · DOI
- Priest, J.R., and Ashley, E.A. (2014). Genomics in Clinical Practice, BMJ Publishing Group Ltd and British Cardiovascular Society. · DOI
- Jacob, 2013, Genomics in clinical practice: Lessons from the front lines, Sci. Transl. Med., 5, 194cm5, 10.1126/scitranslmed.3006468 · DOI
- Shieh, 2016, Breast cancer risk prediction using a clinical risk model and polygenic risk score, Breast Cancer Res. Treat., 159, 513, 10.1007/s10549-016-3953-2 · DOI · Paper page
- Bowdin, 2016, Recommendations for the integration of genomics into clinical practice, Genet. Med., 18, 1075, 10.1038/gim.2016.17 · DOI
- Chatterjee, 2016, Developing and evaluating polygenic risk prediction models for stratified disease prevention, Nat. Rev. Genet., 17, 392, 10.1038/nrg.2016.27 · DOI · Paper page
- Lello, 2019, Genomic prediction of 16 complex disease risks including heart attack, diabetes, breast and prostate cancer, Sci. Rep., 9, 15286, 10.1038/s41598-019-51258-x · DOI
- Liu, 2018, Genome-wide polygenic risk predictors for kidney disease, Nat. Rev. Nephrol., 14, 723, 10.1038/s41581-018-0067-6 · DOI
- Torkamani, 2018, The personal and clinical utility of polygenic risk scores, Nat. Rev. Genet., 19, 581, 10.1038/s41576-018-0018-x · DOI · Paper page
- Nelson, 2019, Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: Updated evidence report and systematic review for the US Preventive Services Task Force, JAMA, 322, 666, 10.1001/jama.2019.8430 · DOI
- Meisner, 2020, Combined Utility of 25 Disease and Risk Factor Polygenic Risk Scores for Stratifying Risk of All-Cause Mortality, Am. J. Hum. Genet., 107, 418, 10.1016/j.ajhg.2020.07.002 · DOI
- Lewis, 2020, Polygenic risk scores: From research tools to clinical instruments, Genome Med., 12, 1, 10.1186/s13073-020-00742-5 · DOI · Paper page
- Lewis, 2021, Polygenic risk scores: From research tools to clinical instruments, Genome Med., 13, 14, 10.1186/s13073-021-00829-7 · DOI · Paper page
- Kulm, S., Marderstein, A., Mezey, J., and Elemento, O. (2021). A systematic framework for assessing the clinical impact of polygenic risk scores. medRxiv. · doi:10.2139/ssrn.3808292
- Inouye, 2018, Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults: Implications for Primary Prevention, J. Am. Coll. Cardiol., 72, 1883, 10.1016/j.jacc.2018.07.079 · DOI · Paper page
- Piepoli, 2016, Guidelines: Editor’s choice: 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR), Eur. Heart J., 37, 2315, 10.1093/eurheartj/ehw106 · DOI · Paper page
- Wolf, 1994, Stroke risk profile: Adjustment for antihypertensive medication. The Framingham Study, Stroke, 25, 40, 10.1161/01.STR.25.1.40 · DOI · Paper page
- Vasan, 2008, General cardiovascular risk profile for use in primary care, Circulation, 117, 743, 10.1161/CIRCULATIONAHA.107.699579 · DOI · Paper page
- Conroy, 2003, Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project, Eur. Heart J., 24, 987, 10.1016/S0195-668X(03)00114-3 · DOI · Paper page
- Woodward, 2007, Adding social deprivation and family history to cardiovascular risk assessment: The ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC), Heart, 93, 172, 10.1136/hrt.2006.108167 · DOI · Paper page
- Coupland, 2007, Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: Prospective open cohort study, BMJ, 335, 136, 10.1136/bmj.39261.471806.55 · DOI · Paper page
- Hippisley-Cox, J., Coupland, C., and Brindle, P. (2017). Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: Prospective cohort study. BMJ, 357. · DOI · Paper page
- Goff, 2014, 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J. Am. Coll. Cardiol., 63, 2935, 10.1016/j.jacc.2013.11.005 · DOI · Paper page
- Colantonio, 2017, Performance of the atherosclerotic cardiovascular disease pooled cohort risk equations by social deprivation status, J. Am. Heart Assoc., 6, e005676, 10.1161/JAHA.117.005676 · DOI
- Giampaoli, 2007, CUORE: A Sustainable Cardiovascular Disease Prevention Strategy, Eur. J. Cardiovasc. Prev. Rehabil., 14, 161, 10.1097/HJR.0b013e328157f3e5 · DOI
- Hajifathalian, 2015, A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): A pooled analysis of prospective cohorts and health examination surveys, Lancet Diabetes Endocrinol., 3, 339, 10.1016/S2213-8587(15)00081-9 · DOI · Paper page
- Ridker, 2007, Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: The Reynolds Risk Score, JAMA, 297, 611, 10.1001/jama.297.6.611 · DOI · Paper page
- Mendis, 2007, World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: Assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries, J. Hypertens., 25, 1578, 10.1097/HJH.0b013e3282861fd3 · DOI · Paper page
- Nobel, 2014, MyRisk_Stroke calculator: A personalized stroke risk assessment tool for the general population, J. Clin. Neurol., 10, 1, 10.3988/jcn.2014.10.1.1 · DOI
- Kothari, 2002, UKPDS 60: Risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine, Stroke, 33, 1776, 10.1161/01.STR.0000020091.07144.C7 · DOI
- Knowles, J.W., and Ashley, E.A. (2018). Cardiovascular disease: The rise of the genetic risk score. PLoS Med., 15. · DOI · Paper page
- Attia, 2020, Artificial intelligence in cardiology: Present and future, Mayo Clinic Proceedings, Volume 95, 1015, 10.1016/j.mayocp.2020.01.038 · DOI · Paper page
- Commandeur, 2020, Machine learning to predict the long-term risk of myocardial infarction and cardiac death based on clinical risk, coronary calcium, and epicardial adipose tissue: A prospective study, Cardiovasc. Res., 116, 2216, 10.1093/cvr/cvz321 · DOI
- Jamthikar, 2020, Cardiovascular/stroke risk predictive calculators: A comparison between statistical and machine learning models, Cardiovasc. Diagn. Ther., 10, 919, 10.21037/cdt.2020.01.07 · DOI
- Yang, 2015, Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores, Am. J. Hum. Genet., 97, 576, 10.1016/j.ajhg.2015.09.001 · DOI · Paper page
- Lello, 2018, Accurate genomic prediction of human height, Genetics, 210, 477, 10.1534/genetics.118.301267 · DOI · Paper page
- Aschard, 2019, Efficient Implementation of Penalized Regression for Genetic Risk Prediction, Genetics, 212, 65, 10.1534/genetics.119.302019 · DOI
- Yong, 2020, Genetic Architecture of Complex Traits and Disease Risk Predictors, Sci. Rep., 10, 12055, 10.1038/s41598-020-68881-8 · DOI
- Lello, 2020, Sibling validation of polygenic risk scores and complex trait prediction, Sci. Rep., 10, 13190, 10.1038/s41598-020-69927-7 · DOI
- Privé, F., Vilhjálmsson, B.J., and Mak, T.S. (2021). lassosum2: An updated version complementing LDpred2. bioRxiv.
- Vazquez, 2018, Complex-Trait Prediction in the Era of Big Data, Trends Genet., 34, 746, 10.1016/j.tig.2018.07.004 · DOI
- Bycroft, 2018, The UK Biobank resource with deep phenotyping and genomic data, Nature, 562, 203, 10.1038/s41586-018-0579-z · DOI · Paper page
- Bycroft, C., Freeman, C., Petkova, D., Band, G., Elliott, L.T., Sharp, K., Motyer, A., Vukcevic, D., Delaneau, O., and O’Connell, J. (2017). Genome-wide genetic data on 500,000 UK Biobank participants. bioRxiv, Available online: https://www.biorxiv.org/content/early/2017/07/20/166298. · DOI · Paper page
- Price, 2006, Principal components analysis corrects for stratification in genome-wide association studies, Nat. Genet., 38, 904, 10.1038/ng1847 · DOI · Paper page
- Mathieson, 2012, Differential confounding of rare and common variants in spatially structured populations, Nat. Genet., 44, 243, 10.1038/ng.1074 · DOI · Paper page
- Bhatia, G., Gusev, A., Loh, P.R., Finucane, H., Vilhjálmsson, B.J., Ripke, S., Purcell, S., Stahl, E., Daly, M., and de Candia, T.R. (2016). Subtle stratification confounds estimates of heritability from rare variants. bioRxiv. · DOI
- Bellenguez, 2016, Accuracy of heritability estimations in presence of hidden population stratification, Sci. Rep., 6, 26471, 10.1038/srep26471 · DOI
- Guo, 2018, Global genetic differentiation of complex traits shaped by natural selection in humans, Nat. Commun., 9, 1865, 10.1038/s41467-018-04191-y · DOI
- Sohail, 2019, Polygenic adaptation on height is overestimated due to uncorrected stratification in genome-wide association studies, eLife, 8, e39702, 10.7554/eLife.39702 · DOI · Paper page
- Barton, 2019, Population genetics: Why structure matters, eLife, 8, e45380, 10.7554/eLife.45380 · DOI
- Berg, 2019, Reduced signal for polygenic adaptation of height in UK Biobank, eLife, 8, e39725, 10.7554/eLife.39725 · DOI · Paper page
- Wray, 2019, Complex trait prediction from genome data: Contrasting EBV in livestock to PRS in humans: Genomic prediction, Genetics, 211, 1131, 10.1534/genetics.119.301859 · DOI
- Bitarello, 2020, Polygenic scores for height in admixed populations, G3 Genes Genomes Genet., 10, 4027, 10.1534/g3.120.401658 · DOI
- Trochet, H., and Hussin, J. (2020). Fine-scale population structure confounds genetic risk scores in the ascertainment population. bioRxiv.
- Refoyo-Martínez, A., Liu, S., Jørgensen, A.M., Jin, X., Albrechtsen, A., Martin, A.R., and Racimo, F. (2021). How robust are cross-population signatures of polygenic adaptation in humans?. bioRxiv. · DOI
- Marquez-Luna, C., Gazal, S., Loh, P.R., Furlotte, N., Auton, A., and Price, A.L. (2018). Modeling functional enrichment improves polygenic prediction accuracy in UK Biobank and 23andMe data sets. bioRxiv, Available online: https://www.biorxiv.org/content/early/2018/07/24/375337.full.pdf. · DOI
- Elhaik, E. (2021). Why most Principal Component Analyses (PCA) in population genetic studies are wrong. bioRxiv. · DOI
- Wertz, 2019, Using DNA from mothers and children to study parental investment in children’s educational attainment, Child Dev., 19, 1745
- Bates, 2018, The nature of nurture: Using a virtual-parent design to test parenting effects on children’s educational attainment in genotyped families, Twin Res. Hum. Genet., 21, 73, 10.1017/thg.2018.11 · DOI
- Wand, 2020, Improving reporting standards for polygenic scores in risk prediction studies, Nature, 591, 211, 10.1038/s41586-021-03243-6 · DOI · Paper page
- Carlson, 2013, Generalization and Dilution of Association Results from European GWAS in Populations of Non-European Ancestry: The PAGE Study, PLoS Biol., 11, 1, 10.1371/journal.pbio.1001661 · DOI · Paper page
- Privé, F., Aschard, H., Carmi, S., Folkersen, L., Hoggart, C., O’Reilly, P.F., and Vilhjálmsson, B.J. (2021). High-resolution portability of 245 polygenic scores when derived and applied in the same cohort. medRxiv. · doi:10.1101/2021.02.05.21251061
- Tibshirani, 1996, Regression shrinkage and selection via the lasso, J. R. Stat. Soc. Ser. B, 58, 267, 10.1111/j.2517-6161.1996.tb02080.x · DOI · Paper page
- Donoho, 2005, Sparse nonnegative solution of underdetermined linear equations by linear programming, Proc. Natl. Acad. Sci. USA, 102, 9446, 10.1073/pnas.0502269102 · DOI · Paper page
- Donoho, D., and Stodden, V. (2006, January 16–21). Breakdown Point of Model Selection When the Number of Variables Exceeds the Number of Observations. Proceedings of the 2006 IEEE International Joint Conference on Neural Network Proceedings, Vancouver, BC, Canada. · doi:10.1109/ijcnn.2006.246934
- Donoho, 2009, Message-passing algorithms for compressed sensing, Proc. Natl. Acad. Sci. USA, 106, 18914, 10.1073/pnas.0909892106 · DOI · Paper page
- Donoho, 2010, Precise Undersampling Theorems, Proc. IEEE, 98, 913, 10.1109/JPROC.2010.2045630 · DOI
- Boerwinkle, 1992, Apolipoprotein (a) gene accounts for greater than 90% of the variation in plasma lipoprotein (a) concentrations, J. Clin. Investig., 90, 52, 10.1172/JCI115855 · DOI · Paper page
- Kraft, 1992, The apolipoprotein (a) gene: A transcribed hypervariable locus controlling plasma lipoprotein (a) concentration, Hum. Genet., 90, 220, 10.1007/BF00220066 · DOI · Paper page
- Austin, 1992, Lipoprotein (a) in women twins: Heritability and relationship to apolipoprotein (a) phenotypes, Am. J. Hum. Genet., 51, 829
- Rao, 2015, Heritability of biomarkers of oxidized lipoproteins: Twin pair study, Arterioscler. Thromb. Vasc. Biol., 35, 1704, 10.1161/ATVBAHA.115.305306 · DOI
- Frank, 1988, The apolipoprotein (a) gene resides on human chromosome 6q26–27, in close proximity to the homologous gene for plasminogen, Hum. Genet., 79, 352, 10.1007/BF00282175 · DOI
- Drayna, 1988, Genetic linkage between lipoprotein (a) phenotype and a DNA polymorphism in the plasminogen gene, Genomics, 3, 230, 10.1016/0888-7543(88)90084-5 · DOI
- Lindahl, 1989, The gene for the Lp (a)-specific glycoprotein is closely linked to the gene for plasminogen on chromosome 6, Hum. Genet., 81, 149, 10.1007/BF00293891 · DOI
- Tsimikas, 2012, Lipoprotein (a) as a potential causal genetic risk factor of cardiovascular disease: A rationale for increased efforts to understand its pathophysiology and develop targeted therapies, J. Am. Coll. Cardiol., 60, 716, 10.1016/j.jacc.2012.04.038 · DOI · Paper page
- Mack, 2017, A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms, J. Lipid Res., 58, 1834, 10.1194/jlr.M076232 · DOI · Paper page
- Schmidt, 2006, Genetics of the Lp (a)/apo (a) system in an autochthonous Black African population from the Gabon, Eur. J. Hum. Genet., 14, 190, 10.1038/sj.ejhg.5201512 · DOI
- Hoekstra, 2021, Genome-wide association study highlights APOH as a novel locus for lipoprotein (a) levels—brief report, Arterioscler. Thromb. Vasc. Biol., 41, 458, 10.1161/ATVBAHA.120.314965 · DOI
- Schmidt, 2016, Structure, function, and genetics of lipoprotein (a), J. Lipid Res., 57, 1339, 10.1194/jlr.R067314 · DOI · Paper page
- Zeng, 2019, Improved polygenic prediction by Bayesian multiple regression on summary statistics, Nat. Commun., 10, 5086, 10.1038/s41467-019-12653-0 · DOI · Paper page
- Coltell, O., Asensio, E.M., Sorlí, J.V., Barragán, R., Fernández-Carrión, R., Portolés, O., Ortega-Azorín, C., Martínez-Lacruz, R., González, J.I., and Zanón-Moreno, V. (2019). Genome-wide association study (GWAS) on bilirubin concentrations in subjects with metabolic syndrome: Sex-specific gwas analysis and gene-diet interactions in a mediterranean population. Nutrients, 11. · DOI
- Bielinski, S.J., Chai, H.S., Pathak, J., Talwalkar, J.A., Limburg, P.J., Gullerud, R.E., Sicotte, H., Klee, E.W., Ross, J.L., and Kocher, J.P.A. (2011). Mayo genome consortia: A genotype-phenotype resource for genome-wide association studies with an application to the analysis of circulating bilirubin levels. Mayo Clin. Proc., 86. · doi:10.4016/31593.01
- Kathiresan, S., Manning, A.K., Demissie, S., D’Agostino, R.B., Surti, A., Guiducci, C., Gianniny, L., Burtt, N.P., Melander, O., and Orho-Melander, M. (2007). A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study. BMC Med Genet., 8. · DOI · Paper page
- Cockcroft, 1976, Prediction of creatinine clearance from serum creatinine, Nephron, 16, 31, 10.1159/000180580 · DOI · Paper page
- Miller, 2008, Reporting estimated GFR: A laboratory perspective, Am. J. Kidney Dis., 52, 645, 10.1053/j.ajkd.2008.07.032 · DOI
- Levey, 2009, A new equation to estimate glomerular filtration rate, Ann. Intern. Med., 150, 604, 10.7326/0003-4819-150-9-200905050-00006 · DOI · Paper page
- Levey, 2010, Estimating GFR using the CKD epidemiology collaboration (CKD-EPI) creatinine equation: More accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions, Am. J. Kidney Dis., 55, 622, 10.1053/j.ajkd.2010.02.337 · DOI · Paper page
- Pugh, 1973, Transection of the oesophagus for bleeding oesophageal varices, J. Br. Surg., 60, 646, 10.1002/bjs.1800600817 · DOI · Paper page
- Kamath, 2007, The model for end-stage liver disease (MELD), Hepatology, 45, 797, 10.1002/hep.21563 · DOI · Paper page
- Lee, 2012, Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011, Hepatology, 55, 965, 10.1002/hep.25551 · DOI · Paper page
- Loos, 2014, The bigger picture of FTO—the first GWAS-identified obesity gene, Nat. Rev. Endocrinol., 10, 51, 10.1038/nrendo.2013.227 · DOI · Paper page
- Vattikuti, 2014, Applying compressed sensing to genome-wide association studies, GigaScience, 3, 10, 10.1186/2047-217X-3-10 · DOI
- Pedregosa, 2011, Scikit-learn: Machine Learning in Python, J. Mach. Learn. Res., 12, 2825
- Chang, 2015, Second-generation PLINK: Rising to the challenge of larger and richer datasets, Gigascience, 4, s13742-015, 10.1186/s13742-015-0047-8 · DOI · Paper page
Cited by
Revolutionizing healthcare: the role of artificial intelligence in clinical practice
Alowais, S. A., Alghamdi, S. S., Alsuhebany, N., Alqahtani, T., Alshaya, A. I., Almohareb, S. N., Aldairem, A., Alrashed, M., Bin Saleh, K., Badreldin, H. A., et al. (2023) · BMC Medical Education · doi:10.1186/s12909-023-04698-z · Cited by 3,146
Social-Science Genomics: Progress, Challenges, and Future Directions
Benjamin, D., Cesarini, D., Turley, P., & Young, A. S. (2024) · doi:10.3386/w32404 · Cited by 20
Metadata
- Authors
- Widen, E., Raben, T. G., Lello, L., & Hsu, S. D. H.
- Venue
- Genes
- Publisher
- MDPI AG
- Published
- 2021-06-29
- Volume
- 12
- Issue
- 7
- Pages
- 991
- ISSN
- 2073-4425
- Cited by
- 32
- References
- 29
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Machine Learning Prediction of Biomarkers from SNPs and of Disease Risk from Biomarkers in the UK Biobank. https://app.cochat.ai/papers/10.3390/genes12070991
- The paper
- Widen, E., Raben, T. G., Lello, L., & Hsu, S. D. H. (2021). Machine Learning Prediction of Biomarkers from SNPs and of Disease Risk from Biomarkers in the UK Biobank. Genes. https://doi.org/10.3390/genes12070991
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.